GLP-1 and Blindness

KGNU - How On Earth

Inhalt bereitgestellt von KGNU - How On Earth. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von KGNU - How On Earth oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

5M ago 26:58

MP3•Episode-Home

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on November 11, 2025 21:11 (3d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

photo of intermediate macular degeneration c National Institutes of Health

We talk with scientists who report that a common weight loss/diabetes drug known as a GLP-1 receptor agonist (Wegovy, Ozempic for instance) is associated with an increased risk of blindness. The study was published last week in the Journal of the American Medical Association Ophthalmology, about a form of blindness known as “wet” macular degeneration. The scientists we talk with today are Marko Popovic and Reut Shor. We also refer to a different, unrelated study, underway, to evaluate a ketogenic diet and eye health, specifically, whether or not a ketogenic diet can reduce diabetes while providing better protection to the eye.

Executive Producer: Joel Parker
Show Producer: Shelley Schlender

744 Episoden

#Science #KGNU - How On Earth #Natural Sciences #Social Sciences #On Covid19